Unbound MEDLINE

Pulmonary vasculitis. The American review of respiratory disease. [Am Rev Respir Dis] Journal article

 
TitlePulmonary vasculitis.
Author(s)Leavitt RY, Fauci AS 
SourceAm Rev Respir Dis 1986 Jul; 134(1):149-66.
MeSHAdrenal Cortex Hormones
Azathioprine
Behcet Syndrome
Chlorambucil
Connective Tissue Diseases
Cyclophosphamide
Cyclosporins
Drug Combinations
Granuloma
Hemorrhage
Humans
Lung Diseases
Lymphomatoid Granulomatosis
Respiratory Tract Infections
Sulfamethoxazole
Syndrome
Takayasu's Arteritis
Trimethoprim
Trimethoprim-Sulfamethoxazole Combination
Vasculitis
Vasculitis, Allergic Cutaneous
Wegener's Granulomatosis
AbstractThe granulomatous vasculitides frequently involve the lung. These syndromes include Wegener's granulomatosis, allergic angiitis and granulomatosis, and the polyangiitis overlap syndrome. Although not a true systemic vasculitis, necrotizing sarcoid granulomatosis also represents a type of pulmonary vasculitis. It is clear that many infectious agents can cause a picture in the lung that can be confused with granulomatous vasculitis and that an infectious process must be ruled out before a diagnosis of pulmonary vasculitis can be established. Pulmonary vasculitis can be associated with the hypersensitivity vasculitides, and pulmonary hemorrhage can be secondary to pulmonary capillaritis. Therapy of the hypersensitivity vasculitides consists of removing the offending antigen and instituting a limited course of corticosteroids. If the vasculitis is secondary to an underlying disease, such as lymphoma, therapy should be directed at the primary disease. Combination therapy with cyclophosphamide and corticosteroids is effective in the systemic vasculitides and the 5-yr survival rate is approximately 90%.
Languageeng
Pub Type(s)Journal Article
Review
PubMed ID2873770
  
Advertise on this site.